Home » Newsletters » BioWorld Science

BioWorld Science

June 6, 2014

View Archived Issues

DuoGel designed for vaginal and rectal delivery of anti-HIV microbicides

Data from three phase I studies of QGE-031 reported

Repurposing of licensed therapeutic agents to treat human viral infections

Researchers at Novartis patent novel PI3K/mTOR inhibitors for cancer

Karus Therapeutics discloses new HDAC inhibitors

ImaginAb licenses PET imaging agents targeting murine T cells from UCLA

Bristol-Myers Squibb and Syngene extend collaboration in India

NanoString collaborates with Celgene on companion diagnostic test for Revlimid

Protalex reports new data analysis from phase Ib study of PRTX-100 for rheumatoid arthritis

FDA grants orphan drug status to two pancreatic cancer treatments

Bristol-Myers Squibb designs novel TYK2 inhibitors

Researchers at Merck & Co. disclose new SYK inhibitors

Scientists at Purdue Pharma patent new agents for pain and constipation

Array BioPharma's ARRY-797 receives FDA orphan drug status for DCM

ABT-414 plus temozolomide: preliminary efficacy results of a phase I study in glioblastoma

New phase II trial evaluation of PLX-3397 as a single agent in patients with recurrent glioblastoma

GlaxoSmithKline presents first-in-human results for GSK-2636771

microRNAs mir-21 and mir-221 overexpressed in placentas from patients with pre-eclampsia

NIH awards grant to Daktari Diagnostics to support development of HCV diagnostic

Study shows ivacaftor improves lung function in patients with CF

Kadmon confirms initiation of phase Ib/IIa study of KD-019 and trastuzumab

AFFiRiS reports encouraging data from phase II study of AD-04 in Alzheimer's disease

Enrollment open in Advanced Cancer Therapeutics' phase I study of PFK-158

FDA removes clinical hold on phase II study of PEGPH-20 for pancreatic cancer

Ocugen receives orphan designation for OCU-100 in retinitis pigmentosa

EMA validates MAA for Raxone in Leber's hereditary optic neuropathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...